An illustration shows the structure of an inhibitor bound to the active site of membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase. An inhibitor bound to the active site of ...
Last year’s landmark case of “Baby KJ”—the first patient to receive a personalized CRISPR‑based gene therapy—showcased both the promise and the persistent challenges of genome editing. While CRISPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results